Other studies have found that growth differentiation factor-15 (GDF-15) has been proved to be abnormally expressed in metabolic diseases, cardiovascular diseases (atherosclerosis, chronic heart failure, coronary heart disease, etc.), malignant tumors, and other diseases. Here, GDF15 is linked to atherosclerosis.